skip to main content skip to accessibility policy

Articles & Updates – Details

9 June 2011

'Negative Term' SPCs – CJEU's Advocate General Paves the Way

'Negative Term' SPCs – CJEU's Advocate General Paves the Way

The Advocate General of the Court of Justice of the European Union (CJEU) has today issued his opinion on Merck's 'negative term' SPC case. The AG considered that an SPC can be granted for a medicine in the EU even when less than five years have elapsed between the filing date of the basic patent and the date of first EU marketing authorization of that medicine. He also considered that the six-month 'paediatric extension' on an SPC (which is granted when paediatric studies have been carried out on a medicine) should begin from the date the SPC expires, even if this date is before the expiry date of the basic patent.

If followed by the full Court, this opinion will assist applicants to obtain SPC protection and paediatric extensions in Europe even in some cases when the regulatory authorities rapidly grant marketing authorisation for that medicine.

Bookmark and Share

Related Resources

Related People

Partner, Patent Attorney
News

Send to a Friend

We are glad that you have found this page of interest. Please use this form to send your friend an email link to this page.





The details you provide on this page will not be used to send unsolicited e-mail, and will not be sold to a 3rd party.

Follow us

Newsletter subscriptions

In support of our environmental policy we encourage email subscriptions to receive our patent and trade mark newsletters as soon as they are published.








For RSS users

Our RSS news feeds allow you to see when we have added new content to our website so you can get the latest site updates in one place, as soon as they are published.

Social media

Privacy Policy

We are committed to protecting and respecting your privacy. To understand our views and practices regarding your personal data and how we will treat it please see www.dyoung.com/privacypolicy